• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

ACU:AU

Trading has been suspended for ACU:AU

Snapshot for Acuvax Ltd (ACU)

Open: - Day's Range: - Volume: 0
Previous Close: 0.0010 52wk Range: - 1-Yr Rtn: -

Stock Chart for ACU

No chart data available.
  • ACU:AU
  • 1M
  • 1Y
0.0010
Interactive ACU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACU

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. AS51 -
Earnings Per Share (ttm) -0.0006
Est. EPS -
Est. PEG Ratio -
Market Cap (M AUD) 0.00
Shares Outstanding (M) 2,632.97
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACU

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for ACU

Acuvax Limited offers research and development of cancer therapies and vaccines in Australia and North America. The Company develops vaccines against debilitating infectious diseases such as dengue and west nile virus.

Roland Holger BerzinsSecretary
More Company Profile & Key Executives for ACU

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil